Murielle Thinard McLane, MBA

Murielle joined Intuitive Ventures in 2023. She is a senior investor and brings a depth of experience across digital health, diagnostics, and biotech domains to lead investments in companies that are shaping the future of minimally invasive care throughout the patient continuum.

Murielle is a seasoned operator and executive with over 20 years-experience building and scaling organizations as an entrepreneur and Fortune 500 executive. She most recently served as CEO of molecular diagnostics company, Ontera, and as co-founder of Nooma Bio, a life science tools platform focused on detecting cytogenetic abnormalities. She started her foray into venture capital as an Executive in Residence for GE Healthcare Ventures where she helped launch Verana Health, the largest clinical database in medicine empowering physicians and accelerating research for patients. While there she also supported investment in Genome Medical, a telehealth provider of genomic medical insights. Previously, she was a General Manager at McKesson where she oversaw multi-billion dollar P&Ls spanning therapeutics, surgical supplies, services and data analytics and before that worked in strategy and leadership roles at both Genentech and Novartis. Passionate about bridging the gender gap in the C-Suite of venture-backed companies, she served on Springboard Enterprises’ executive council for pharmaceuticals and digital health, a network dedicated to building high-growth, technology-oriented companies led by women.

Murielle holds an MBA from Wharton and started her career in financial services.